pDONR223-EGFR Citations (8)

Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal

---

Articles Citing pDONR223-EGFR

Articles
Declines in Drp1 and parkin expression underlie DNA damage-induced changes in mitochondrial length and neuronal death. Wang DB, Garden GA, Kinoshita C, Wyles C, Babazadeh N, Sopher B, Kinoshita Y, Morrison RS. J Neurosci. 2013 Jan 23;33(4):1357-65. doi: 10.1523/JNEUROSCI.3365-12.2013. PubMed
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma. Sun C, Wang L, Huang S, Heynen GJ, Prahallad A, Robert C, Haanen J, Blank C, Wesseling J, Willems SM, Zecchin D, Hobor S, Bajpe PK, Lieftink C, Mateus C, Vagner S, Grernrum W, Hofland I, Schlicker A, Wessels LF, Beijersbergen RL, Bardelli A, Di Nicolantonio F, Eggermont AM, Bernards R. Nature. 2014 Apr 3;508(7494):118-22. doi: 10.1038/nature13121. Epub 2014 Mar 26. PubMed
CD166-mediated epidermal growth factor receptor phosphorylation promotes the growth of oral squamous cell carcinoma. Jia G, Wang X, Yan M, Chen W, Zhang P. Oral Oncol. 2016 Aug;59:1-11. doi: 10.1016/j.oraloncology.2016.05.010. Epub 2016 Jun 3. PubMed
Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells. Vouri M, Croucher DR, Kennedy SP, An Q, Pilkington GJ, Hafizi S. Oncogenesis. 2016 Oct 24;5(10):e266. doi: 10.1038/oncsis.2016.66. PubMed
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Li Z, Ivanov AA, Su R, Gonzalez-Pecchi V, Qi Q, Liu S, Webber P, McMillan E, Rusnak L, Pham C, Chen X, Mo X, Revennaugh B, Zhou W, Marcus A, Harati S, Chen X, Johns MA, White MA, Moreno C, Cooper LA, Du Y, Khuri FR, Fu H. Nat Commun. 2017 Feb 16;8:14356. doi: 10.1038/ncomms14356. PubMed
HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss. Bartel CA, Jackson MW. PLoS One. 2017 May 2;12(5):e0176778. doi: 10.1371/journal.pone.0176778. eCollection 2017. PubMed
Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane. Werbin JL, Avendano MS, Becker V, Jungmann R, Yin P, Danuser G, Sorger PK. Sci Rep. 2017 Sep 22;7(1):12150. doi: 10.1038/s41598-017-12257-y. PubMed
Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. Strickler JH, Loree JM, Ahronian LG, Parikh AR, Niedzwiecki D, Pereira AAL, McKinney M, Korn WM, Atreya CE, Banks KC, Nagy RJ, Meric-Bernstam F, Lanman RB, Talasaz A, Tsigelny IF, Corcoran RB, Kopetz S. Cancer Discov. 2018 Feb;8(2):164-173. doi: 10.1158/2159-8290.CD-17-1009. Epub 2017 Dec 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.